Cyclacel Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Bio Green Med Solution

28/03/2022 22:01

* Cyclacel Pharmaceuticals Inc  CYCC.OQ  reported a
quarterly
adjusted loss of 54 cents​​ per share for the quarter ended in
December. The mean expectation of three analysts for the quarter
was for a loss of 65 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Cyclacel Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 54 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cyclacel Pharmaceuticals Inc shares had fallen by 18.0%
this
quarter.
    * The company reported a quarterly loss of $5.34 million.
    * Wall Street's median 12-month price target for Cyclacel
Pharmaceuticals Inc is $19.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 28 at 09:01 p.m.  ​All
figures in US dollars unless otherwise stated